Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Teva
Merck
Moodys
Federal Trade Commission
QuintilesIMS
UBS
Cantor Fitzgerald
Chubb

Generated: April 21, 2018

DrugPatentWatch Database Preview

BAYCOL Drug Profile

« Back to Dashboard

When do Baycol patents expire, and when can generic versions of Baycol launch?

Baycol is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in BAYCOL is cerivastatin sodium. Additional details are available on the cerivastatin sodium profile page.
Drug patent expirations by year for BAYCOL
Synonyms for BAYCOL
(+)-Sodium (3R,5S,6E)-7-(4-(p-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoate
(3R,5S,6E)-7-(4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,6E)-7-(4-(p-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,6E)-7-[4-(4-FLUOROPHENYL)-2,6-DIISOPROPYL-5-(METHOXYMETHYL)(PYRIDIN-3-YL)]-3,5-DIHYDROXYHEPT-6-ENOIC ACID
(3R,5S,6E)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
(3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-{4-(4-fluorophenyl)-2,6-bis(1-methylethyl)-5-[(methyloxy)methyl]pyridin-3-yl}-3,5-dihydroxyhept-6-enoic acid
(3R,5S,E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoic acid
(3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid
(E,3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoic acid
(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid
[S-[R*,S*-(E)]]-7-[4-(4-fluorophenyl)-5-methoxymethyl)-2,6bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate
143201-11-0
145599-86-6
599C866
6-Heptanoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-(S-(R*,S*-(E)))-, sodium salt
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, (3R,5S,6E)-
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, (S-(R*,S*-(E)))-
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (3R,5S,6E)-
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))-
6Q18G1060S
7-(4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt
A808034
AB01275453-01
AC1L9J7L
AKOS015967306
AKOS025149364
AKOS030558488
AM91H2KS67
Ambap143201-11-0
AN-31374
AN-31548
API0000459
Bay w 6228
Bay-w-6228
baychol
Baycol (TN)
bayw6228
BC220457
BDBM18376
BIDD:GT0367
C07966
C26H33FNNaO5
C26H33FNO5.Na
CAS-143201-11-0
CCG-100954
cerivastatin
Cerivastatin (INN)
Cerivastatin [INN:BAN]
cerivastatin acid
CERIVASTATIN Na
CERIVASTATIN SODIUM
Cerivastatin sodium (JAN/USAN)
Cerivastatin sodium [USAN]
cerivastatin sodium salt
Cerivastatin sodium salt hydrate
Cerivastatin, sodium salt
Certa
Cervastatin
CHEBI:3558
CHEBI:3559
CHEBI:94755
CHEMBL1200563
CHEMBL1477
CPD000469148
D00889
D03KIA
D07661
D0G9SW
DB00439
DR002845
DSSTox_CID_26488
DSSTox_GSID_46488
DSSTox_RID_81659
DTXSID0046488
DTXSID9022786
GPUADMRJQVPIAS-QCVDVZFFSA-M
GTPL2950
HE229025
HE312065
HMS2051H13
HMS2089B11
HSDB 7357
J-007766
Lipobay
LS-183259
LS-187162
LS-74656
MLS001424071
MolPort-003-845-726
NC00204
NCGC00164625-02
NCGC00164625-04
NCGC00357289-01
Rivastatin
Rivastatin, Baycol, Lipobay
SAM001246554
SCHEMBL16346
SCHEMBL16347
SCHEMBL41887
SCHEMBL41888
SEERZIQQUAZTOL-ANMDKAQQSA-N
SMR000469148
sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoate
sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate
sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-bis(oxidanyl)hept-6-enoate
sodium [S-[R*,S*-(E)]]-7-[4-(4-fluorophenyl)-5-methoxymethyl)-2,6bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate
SR-01000763520
SR-01000763520-3
Statins
Tox21_112244
Tox21_112244_1
Tox21_303882
UNII-6Q18G1060S
UNII-AM91H2KS67
ZINC11330186

US Patents and Regulatory Information for BAYCOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-003 Jun 26, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for BAYCOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-003 Jun 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Army
AstraZeneca
US Department of Justice
Express Scripts
McKinsey
Chubb
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.